AI assistant
Sending…
Novartis AG — Director's Dealing 2018
May 15, 2018
940_dirs_2018-05-15_4900e885-2b00-43e2-9eb8-2cd000bd63c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AveXis, Inc. (AVXS)
CIK: 0001652923
Period of Report: 2018-05-15
Reporting Person: NOVARTIS AG (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.0001 | 36816476 | Indirect |
Footnotes
F1: These shares are owned directly by Novartis AM Merger Corporation, an indirect wholly-owned subsidiary of Novartis AG.
More from Novartis AG
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Annual Report
2026
Feb 4
Regulatory Filings
2026
Jan 16
Regulatory Filings
2026
Jan 16
Regulatory Filings
2026
Jan 16
Regulatory Filings
2026
Jan 16